Emerging point of care tests for influenza: innovation or status quo.

about

Impulsive Enzymes: A New Force in Mechanobiology Performance of the molecular Alere I influenza A&B test compared to that of the xpert flu A/B assay.Evaluation of the Sofia Influenza A + B fluorescent immunoassay for the rapid diagnosis of influenza A and B.

P2860

Q30389540-75CA411A-C291-4BB9-AC61-E49B999CD704 Q34983129-9F3936A7-41C7-49A8-A57F-CFA83FB48D45 Q42214793-5D97A399-3091-41F6-8255-DCE4BF3ADAA7

P2860

Emerging point of care tests for influenza: innovation or status quo.

Item

http://www.wikidata.org/entity/Q49396437

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Emerging point of care tests for influenza: innovation or status quo.

@en

Emerging point of care tests for influenza: innovation or status quo.

@nl

type

Item

label

Emerging point of care tests for influenza: innovation or status quo.

@en

Emerging point of care tests for influenza: innovation or status quo.

@nl

prefLabel

Emerging point of care tests for influenza: innovation or status quo.

@en

Emerging point of care tests for influenza: innovation or status quo.

@nl

P1476

Emerging point of care tests for influenza: innovation or status quo

@en

P2093

Adeoluwa Tayo

http://www.w3.org/2001/XMLSchema#string

Joanna Ellis

http://www.w3.org/2001/XMLSchema#string

P2860

Point of care testing.

Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1.

Evaluation of the Xpert Flu A Panel nucleic acid amplification-based point-of-care test for influenza A virus detection and pandemic H1 subtyping.

Detection of oseltamivir resistance during treatment of 2009 H1N1 influenza virus infection in immunocompromised patients: utility of cycle threshold values of qualitative real-time reverse transcriptase PCR.

Evaluation of the Quidel QuickVue test for detection of influenza A and B viruses in the pediatric emergency medicine setting by use of three specimen collection methods.

Near patient testing for influenza in children in primary care: comparison with laboratory test

Near-patient testing will improve the control of sexually transmitted infections: the arguments in favour

Comparison of lateral-flow immunoassay and enzyme immunoassay with viral culture for rapid detection of influenza virus in nasal wash specimens from children.

Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection.

Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.

P304

291-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1750-2659.2011.00306.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sue Simpson

D Ward

Luan Linden-Phillips

P577

2011-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51818945

http://www.w3.org/2001/XMLSchema#string

P698

22103966

http://www.w3.org/2001/XMLSchema#string

P932

5779804

http://www.w3.org/2001/XMLSchema#string

Emerging point of care tests for influenza: innovation or status quo.

about

P2860

P2860

Emerging point of care tests for influenza: innovation or status quo.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932